masoprocol has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Ding, T; Ji, J; Jiang, X; Li, W; Li, X; Liang, G; Tang, Q; Wei, T; Weng, B; Wu, J | 1 |
| Giacalone, NJ; Lu, B; Sun, Y | 1 |
| Ahn, MC; Braun, DP; Casey, L; Chu, E; Harris, JE; Siziopikou, KP; Wilbanks, G | 1 |
3 other study(ies) available for masoprocol and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Discovery; Humans; Lung Neoplasms; Masoprocol; Mice; Phosphorylation; Protein Kinase Inhibitors; Receptor, Fibroblast Growth Factor, Type 1; Xenograft Model Antitumor Assays | 2015 |
Terameprocol (tetra-O-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma.
Topics: Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Masoprocol; Radiation-Sensitizing Agents; Sp1 Transcription Factor; Survivin; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2011 |
Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patients to modulation of arachidonic acid metabolism.
Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Carcinoma, Non-Small-Cell Lung; Dinoprostone; Humans; Indomethacin; Lung Neoplasms; Macrophages; Masoprocol; Monocytes; SRS-A | 1993 |